Stock comparison

JNJvsMSFT

Johnson & Johnson vs Microsoft Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

JNJ

Johnson & Johnson

$226.16

+9.50%

Pharmaceuticals$585.7BNYSE

MSFT

Microsoft Corp

$424.16

-12.99%

Technology$2.77TNASDAQ

60-day price, rebased to 100

JNJ +2.11% · MSFT +2.41%

Round-by-round

JNJ 1·MSFT 3· 2 ties

EdgeJNJ

Valuation upside

-36.40% vs -57.00% to DCF fair value

EdgeMSFT

Balance-sheet strength

Altman Z 5.08 vs 7.81

Tie

Fundamental quality

Piotroski 4.00 vs 4.00 (of 9)

Tie

Growth + margins

Rule-of-40 26.60 vs 25.40

EdgeMSFT

60-day momentum

+2.11% vs +2.41% price return

EdgeMSFT

Market-cap liquidity

$585.7B vs $2.77T

Verdict

Across 6 categories, MSFT takes the edge with 3 wins to 1 (and 2 ties). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy on JNJ or MSFT

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.